x

CytoMed Therapeutics Ltd (Nasdaq:GDTC)

Health Care/Life Sciences • Biotechnology
CIK 1873093
Company

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.

Address
1 Commonwealth Lane
No. 08-22, One Commonwealth
Singapore, CE 149544
Employees
34
Stock Info
Close
$2.7500
Day Range
2.7269 - 2.7600
52 Week Range
1.2000 - 4.0499
Average volume
198.76K
Short Interest
147.8K (02/14/25)
% of Float Shorted
3.06%
Market Cap
$31.85M
Revenue
N/A
Net Income
-$3.08M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.1969
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Chee Kong Choo
Director & Chief Clinical Officer
Tien Wee Luk
Independent Director
Yuin Han Loh
Independent Director
Chak Hua Yew
Independent Director
Kei Wei Leong
Independent Director
Tao Wu
Independent Director
Keng Kiat Toh
SEC filings
DateFormEvent
5 Dec, 2024 6-K
20 Nov, 2024 6-K
4 Nov, 2024 144
7 Oct, 2024 6-K
3 Oct, 2024 6-K
30 Sep, 2024 6-K
24 Jun, 2024 6-K/A
20 Jun, 2024 6-K
24 May, 2024 6-K
23 May, 2024 SC 13G/A
25 Apr, 2024 6-K/A
24 Apr, 2024 6-K
22 Apr, 2024 20-F
18 Mar, 2024 6-K
4 Mar, 2024 6-K
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
29 Jan, 2024 6-K
17 Nov, 2023 6-K
25 Sep, 2023 6-K
1 Aug, 2023 6-K
6 Jul, 2023 6-K
19 May, 2023 SC 13D
1 May, 2023 20-F
24 Apr, 2023 SC 13G
21 Apr, 2023 SC 13D
18 Apr, 2023 6-K
17 Apr, 2023 3
17 Apr, 2023 424B4 IPO completed
17 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 CERT
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
31 Mar, 2023 CORRESP
31 Mar, 2023 EFFECT
31 Mar, 2023 FWP
31 Mar, 2023 SEC STAFF
31 Mar, 2023 CORRESP
31 Mar, 2023 CORRESP
30 Mar, 2023 F-1/A
30 Mar, 2023 CORRESP
30 Mar, 2023 8-A12B
29 Mar, 2023 UPLOAD
28 Mar, 2023 F-1/A
16 Mar, 2023 F-1/A
15 Mar, 2023 CORRESP
27 Feb, 2023 FWP
24 Feb, 2023 UPLOAD
21 Feb, 2023 F-1/A
21 Feb, 2023 CORRESP
9 Feb, 2023 UPLOAD
1 Feb, 2023 F-1/A
31 Jan, 2023 CORRESP
30 Nov, 2022 UPLOAD
30 Nov, 2022 SEC STAFF
18 Nov, 2022 CORRESP
18 Nov, 2022 F-1
19 Oct, 2022 UPLOAD
30 Sep, 2022 DRS/A
18 Jan, 2022 DRSLTR
7 Jan, 2022 UPLOAD
20 Dec, 2021 DRS/A
17 Dec, 2021 DRSLTR
2 Dec, 2021 UPLOAD
19 Nov, 2021 DRSLTR
19 Nov, 2021 DRS/A
26 Oct, 2021 UPLOAD
28 Sep, 2021 DRS
Last update:2025-03-06 12:31:38.350314
CytoMed Therapeutics Ltd by TradingView

Sign Up to Subscribe